BOUNDLESS BIO INC (BOLD) Stock Analyst Ratings
NASDAQ:BOLD - Nasdaq - US10170A1007 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to BOLD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.3. This target is 900% above the current price.
BOLD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BOLD.
In the previous month the buy percentage consensus was at a similar level.
BOLD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-13 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-04-22 | Leerink Partners | Initiate | Outperform |
| 2024-04-22 | Guggenheim | Initiate | Buy |
| 2024-04-22 | Piper Sandler | Initiate | Overweight |